mebendazole has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies
Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.
Squamous Cell Carcinoma of Head and Neck: The most common type of head and neck carcinoma that originates from cells on the surface of the NASAL CAVITY; MOUTH; PARANASAL SINUSES, SALIVARY GLANDS, and LARYNX. Mutations in TNFRSF10B, PTEN, and ING1 genes are associated with this cancer.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Head and neck squamous cell carcinoma (HNSCC) is one of the most common and aggressive types of human cancers worldwide." | 1.46 | Anthelmintic mebendazole enhances cisplatin's effect on suppressing cell proliferation and promotes differentiation of head and neck squamous cell carcinoma (HNSCC). ( Chen, L; Fan, J; Gao, L; Guo, D; Haydon, RC; He, TC; Hu, X; Huang, E; Huang, J; Ji, P; Li, L; Li, Y; Liao, J; Liu, F; Liu, J; Luo, W; Luu, HH; Ma, C; Qu, X; Song, D; Song, J; Wei, Q; Wu, T; Yu, X; Zhang, F; Zhang, H; Zhang, Z; Zou, Y, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, F | 1 |
| Li, Y | 1 |
| Zhang, H | 1 |
| Huang, E | 1 |
| Gao, L | 1 |
| Luo, W | 1 |
| Wei, Q | 1 |
| Fan, J | 1 |
| Song, D | 1 |
| Liao, J | 1 |
| Zou, Y | 1 |
| Liu, F | 1 |
| Liu, J | 1 |
| Huang, J | 1 |
| Guo, D | 1 |
| Ma, C | 1 |
| Hu, X | 1 |
| Li, L | 1 |
| Qu, X | 1 |
| Chen, L | 1 |
| Yu, X | 1 |
| Zhang, Z | 1 |
| Wu, T | 1 |
| Luu, HH | 1 |
| Haydon, RC | 1 |
| Song, J | 1 |
| He, TC | 1 |
| Ji, P | 1 |
1 other study available for mebendazole and Squamous Cell Carcinoma of Head and Neck
| Article | Year |
|---|---|
Anthelmintic mebendazole enhances cisplatin's effect on suppressing cell proliferation and promotes differentiation of head and neck squamous cell carcinoma (HNSCC).
Topics: Animals; Antinematodal Agents; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Diff | 2017 |